Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Receivables (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Change in Receivables data on record, last reported at $2.1 million in Q4 2025.

  • For Q4 2025, Change in Receivables rose 225.61% year-over-year to $2.1 million; the TTM value through Oct 2025 reached $6.5 million, up 1180.87%, while the annual FY2025 figure was $6.7 million, 1009.31% up from the prior year.
  • Change in Receivables reached $2.1 million in Q4 2025 per KEQU's latest filing, up from -$5.5 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $6.3 million in Q2 2022 and bottomed at -$5.5 million in Q3 2025.
  • Average Change in Receivables over 5 years is $832050.0, with a median of $782000.0 recorded in 2021.
  • Peak YoY movement for Change in Receivables: crashed 924.0% in 2024, then soared 443.75% in 2025.
  • A 5-year view of Change in Receivables shows it stood at $2.1 million in 2021, then crashed by 65.99% to $725000.0 in 2022, then tumbled by 72.41% to $200000.0 in 2023, then plummeted by 924.0% to -$1.6 million in 2024, then soared by 225.61% to $2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Receivables were $2.1 million in Q4 2025, -$5.5 million in Q3 2025, and $4.9 million in Q2 2025.